Colgate-Palmolive Company (CL) research: valuation against peers, fundamentals over time, risk and news coverage
CL
Colgate-Palmolive CompanyNo data in this window.
Every report in our own archive tagged with this symbol, newest first — fetched from the archive alongside the market data.
- SPECIAL REPORTNEUTRALRising Treasury Yields Test Equity Resilience as Dollar Firms in Narrow Ranges
Equities continue to absorb an upward drift in long-end Treasury yields, with Strategas arguing the ascent must go considerably further before it forces a selloff. A mostly firmer but range-bound dollar and renewed focus on dividend sustainability across telecoms, REITs and payments underscore a market repricing duration rather than direction.
- SPECIAL REPORTBEARISHInsider Selling Wave Sweeps US Corporates as Executives Cash Out Across Tech, Healthcare and Media
A dense cluster of insider disposals spanning Thermo Fisher, Block, Magnite, Colgate-Palmolive, IFF, Aurora Innovation, Tenet Healthcare, Accel Entertainment, Cohen & Co, Gevo and Warner Bros. Discovery signals executives are trimming exposure after a powerful equity run. While individually routine, the aggregate pattern is a classic late-cycle tell.
Every figure on this page is fetched and computed in your browser from free public sources — end-of-day prices and reported financials from Yahoo Finance's open endpoints, and our own archive for the coverage panel. Fundamental history on the free tier runs about four fiscal years and five quarters. Data is best-effort and unaudited; this is market research, not investment advice.